SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as traders position ahead of the company's upcoming Q2 earnings report, with retail sentiment shifting to extremely bullish on expectations of a revenue and EPS beat given management's historically conservative guidanceconsensus calls for roughly $145.5 million in quarterly revenue, up more than 12% year over year. The QNX physical-AI narrative is amplifying the buzz: traders highlight NVIDIA's adoption of QNX 8.0 for automotive and physical AI operating systems, a Sift-QNX partnership to stream telemetry from physical AI systems, and speculation that an Alloy Kore win could soon become visible in the roughly $950 million QNX royalty backlog, which management previously said contained no Alloy Kore business. The community remains split, howeveran active short camp repeatedly urges 'short every pop' into the report, some skeptics argue past beats came only from lowered guidance, and longs counter that QNX's embedded-software footprint is deeply undervalued as they watch for a breakout from single-digit prices.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBAR is trending on regulatory-clarity speculation, with the Clarity Act  the crypto market-structure bill that would split SEC and CFTC oversight of digital assets  dominating the conversation. Traders are debating the bill's fate after a procedural vote to begin debate: some blame senators who voted against it and accuse Democrats of blocking it for political reasons ahead of the midterms, while others insist the vote was merely procedural. Several community members link the token's brief pump and subsequent fade to Clarity Act headlines, though skeptics counter that HBAR is unlikely to sustain a move until the bill actually passes. A secondary thread covers Grayscale's withdrawal of its HBAR ETF filing, which some traders speculate contributed to the pullback and others dismiss as irrelevant to the long-term thesis. Sentiment is otherwise split, with long-term holders citing network growth, enterprise adoption, and infrastructure build-out, while frustrated traders point to rejected resistance near $0.08, bearish technicals, and suspected market-maker manipulation.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Speculation that Novo Nordisk could pursue a large acquisition or partnership of Viking Therapeutics is dominating the ticker, sparked by Novo's statement that its balance sheet could support deals well beyond the small bolt-ons typical of pharma as it battles Eli Lilly in obesity. Traders repeatedly cast VK2735, Viking's GLP-1/GIP dual agonist viewed as a potential tirzepatide rival, as the asset that would make Viking a logical target, and some link the stock's move to Novo's own slide on pipeline concerns; others argue Big Pharma M&A hype around Viking is overblown. No bid or partnership has been confirmed, so the deal talk remains speculation. Underneath is intense anticipation of VK2735's Phase 3 readouts, which many view as the stock's defining upcoming catalyst: bulls say the lack of a pre-data run-up plus heavy short interest sets up a strong reaction, while bears cite GI tolerability risks, slower planned Phase 3 titration, dilution, and criticism of CEO Brian Lian's communication as setup for a sell-the-news disappointment.

ProShares Trust - ProShares Bitcoin ETF

ProShares Bitcoin Strategy ETF

BITO's collapsed monthly distribution is dominating the conversation, with holders reacting to a payout of less than a penny per share  one figure cited is 0.006117  and asking why the dividend 'fell off a cliff.' Traders are split on whether the fund is still worth holding: some argue there is no reason to own it without meaningful distributions, while long-term holders defend the position, noting the fund's futures-based design  BITO distributes realized gains when its bitcoin futures contracts are rolled, so payouts shrink when bitcoin declines. Several traders tie the weak distribution to bitcoin's own slump, with chatter about $62,000 support, a possible bottom forming, and a broader market selloff dragging the ETF lower alongside equities. Questions about ex-dividend dates and next-month payout guesses continue to drive engagement.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin ($BTC.X) is trending on a sharp rally into the mid-$80Ks, with traders pointing to a confirmed weekly higher high and bullish engulfing candle as breakout confirmation, and some sharing a linked writeup arguing $86K marks the start of a new bull market. The dominant conversation is a bull-versus-bear fight: bulls celebrate squeezed shorts, mock earlier calls for $30K$71K retests, and argue the industry has matured enough that future drawdowns will be shallower, while skeptics call the move a trap  some plan to scale into shorts, cite an upside/downside liquidity imbalance, and note BTC-linked names like $MSTR aren't keeping pace with the coin. Others frame the rebound as part of a broader risk-on move across equities rather than a crypto-specific catalyst, with additional chatter around profit-taking and whether $90K$100K is the next test.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD's rally to a $1 trillion market cap is dominating the conversation, with the chipmaker joining Nvidia, Broadcom, and Micron among U.S. chip companies to reach the milestone after a run of more than 175% year-to-date. Retail sentiment has turned extremely bullish, and traders frame AMD as the "indispensable" No. 2 AI-chip supplier to Nvidia, with the milestone fueling FOMO-style buying chatter and repeated questions like "why is this up so much?" and "how does this not sell off?"The community is split on sustainability. Squeeze believers say short sellers are "getting wrecked," warn against shorting the move, and note the stock has climbed roughly $170 during the rally, while one trader cites a personal rule that companies reaching $1 trillion fall 15% within four weeks afterward. Valuation skeptics counter that the stock trades near $623 against roughly $2.65 in EPS, argue it can't keep climbing "with no major news other than a 10% price increase," and question buying at all-time highs, with several debating whether to lock in profits or wait for a pullback. Others tie the strength to AI chip-demand optimism around Meta's Muse-driven demand bets and AMD's OpenAI partnership. Speculation about pending company news, unverified insider-selling claims, and complaints about algo-driven market manipulation also circulate.

Maase, Inc. operates as a integrated provider and operator of artificial intelligence (AI) centric full-scene digital systems. The firm focus on areas of flexible energy deployment and intelligent commercial network operation, and provide closed-loop solutions from computing infrastructure, smart hardware and full-scene services, aiming to achieve large-scale implementation of AI technologies across industries. The company was founded by Hai Feng Yu on August 6, 2018 and is headquartered in Qingdao, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

Traders are focused on Maase Inc.'s (MAAS) steady stream of AI announcements, headlined by a run of token-based enterprise AI services contracts around its 'Lingyan Miaoyu' LLM  including an RMB1.65M contract with five compute nodes delivered, client acceptance completed and payment received in full, an RMB7.68M signing, and an RMB10M-plus Zhongchuang Liankong enterprise AI contract targeted for Q3 delivery. Much of the community reads the repeatable news flow as evidence that the company formerly known as Highest Performances Holdings is converting its AI pivot into real B2B revenue, and momentum traders see the stock coiling above key moving averages in a consolidation triangle on expanding volume as a potential breakout setup. More cautious voices want volume and short-interest confirmation before chasing, ask why the stock has dropped despite positive releases, and argue the small contract values are execution proof rather than company-changing revenue. Secondary threads include the company's AI security white paper, a consumer access portal for its LLM, and its Huazhi Future subsidiary's moves into energy and robotics.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum's sharp rally is the dominant topic, with traders celebrating gains, noting ETH is outperforming bitcoin, and debating whether the move is the start of a bigger leg higher or a fakeout. A recurring thread centers on short positioning: posts cite heavy leveraged short liquidations across the crypto market  one puts the figure above $575 million  describe shorts as near maximum at these levels, and cheer an anticipated squeeze. Bulls are throwing out targets of $2,700, $3,000, $4,000, and even $5,000, with some claiming an all-time high is closer than expected and one trader attributing the broader crypto recovery to the Federal Reserve's rate decision. Skeptics counter that the bounce is a dead-cat bounce, point to major resistance at the 100-week moving average, flag profit taking and a possible double top, with some declaring the 'bull market canceled' or even warning of a crash. Surrounding chatter includes questions about why BMNR isn't keeping pace with ETH's strength despite MSTR's gains, plus scattered speculation ranging from an unverified rumor of a 0% US crypto capital-gains tax to claims that Solana is outprocessing Ethereum in daily transactions.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Bitcoin's breakout to its highest level since January is lifting crypto-linked stocks and has pushed Coinbase to multi-month highs, though many traders complain the stock is lagging the moves in Bitcoin and MSTR. The community is split between bulls calling for a short squeeze and citing the SEC's tokenized-stock exemption and Coinbase's new retail IPO-allocation access as catalysts, and bears arguing the weak relative price action leaves the stock vulnerable to filling gaps lower.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical (DRTS) is trending on bullish discussion centered on its clinical catalyst calendar. Traders are most focused on an anticipated IDE clearance for the company's Keytruda (pembrolizumab) combination trial  framed by the community as the near-term trigger  along with the expanded IMPACT pancreatic cancer study, which grew from 12 to roughly 4850 patients after physician demand, and upcoming GBM scan readouts. Posts repeatedly cite strong interim results, including a 100% response rate in the Keytruda combination and 100% local disease control in pancreatic patients, as the core bull case alongside a signed Tolmar commercial partnership. Contributing factors traders mention behind the stock's recent strength include a roughly 24% gain over a recent ten-session stretch, the TASE dual-listing announcement, MSCI index inclusion, and an analyst price-target increase from Barclays. The main debate is valuation and participation: bulls argue the market hasn't priced in the multi-trial pipeline and that institutions and momentum traders have yet to arrive, while others point to months of short pressure and note that, as a pre-revenue company, the stock's trajectory hinges on catalysts that remain unconfirmed.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
